Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Vastox Buys Two Firms

April 2, 2007 | A version of this story appeared in Volume 85, Issue 14

U .K. biotech firm Vastox has acquired DanioLabs, a private U.K. drug discovery company, and Dextra Laboratories, a carbohydrate chemistry service company. According to Vastox, the DanioLabs buy, for $30 million, adds two clinical and two preclinical programs in neurological and ophthalmic diseases. The Dextra acquisition, for $3 million, will enhance Vastox' capabilities in carbohydrate chemistry.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.